Back to top
more

VERADIGM INC (MDRX)

(Delayed Data from OTC)

$7.55 USD

7.55
226,006

-0.22 (-2.83%)

Updated May 24, 2024 03:52 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 25% (63 out of 249)

Industry: Technology Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Zoom Video, Capri, Teladoc Health, Allscripts Healthcare Solutions and Masimo highlighted as Zacks Bull and Bear of the Day

by Zacks Equity Research

Zoom Video, Capri, Teladoc Health, Allscripts Healthcare Solutions and Masimo highlighted as Zacks Bull and Bear of the Day

Trina Mukherjee headshot

Coronavirus Puts Digital Health in Focus: 3 Stocks to Watch

by Trina Mukherjee

Let's keep a watch on three stocks that are focusing on digital health to fight against coronavirus.

Here's Why You Should Retain Allscripts in Your Portfolio Now

by Zacks Equity Research

Investor confidence remains high in Allscripts' (MDRX) stock, thanks to solid prospects.

    AllScripts (MDRX) Down 3.6% Since Last Earnings Report: Can It Rebound?

    by Zacks Equity Research

    AllScripts (MDRX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

    Allscripts Offers Telehealth Support Amid Coronavirus Outbreak

    by Zacks Equity Research

    Allscripts (MDRX) offers simplified telehealth implementation to health systems through FollowMyHealth to provide telehealth visit capabilities to their patients quickly.

    Allscripts' Veradigm Business Line Unveils New Solution

    by Zacks Equity Research

    Allscripts' (MDRX) Veradigm business line introduces new solution that will drive growing medication adherence and improve patient care.

    Allscripts (MDRX) Q4 Earnings and Revenues Miss Estimates

    by Zacks Equity Research

    Allscripts (MDRX) fourth-quarter results gain from higher revenues along with growth in bookings. Contraction in both gross and operating margins remains a woe.

    AllScripts Healthcare (MDRX) Lags Q4 Earnings and Revenue Estimates

    by Zacks Equity Research

    AllScripts (MDRX) delivered earnings and revenue surprises of -5.56% and -1.51%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

    Analysts Estimate AllScripts Healthcare (MDRX) to Report a Decline in Earnings: What to Look Out for

    by Zacks Equity Research

    AllScripts (MDRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

    Moving Average Crossover Alert: Allscripts Healthcare Solutions

    by Zacks Equity Research

    Allscripts Healthcare Solutions, Inc. (MDRX) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front.

    Allscripts Expands Partnership With PIH Health Through 2025

    by Zacks Equity Research

    Encouraged by its solid EHR prospects, Allscripts (MDRX) expects a surge in its fourth-quarter 2019 bookings.

    MDRX vs. HMSY: Which Stock Should Value Investors Buy Now?

    by Zacks Equity Research

    MDRX vs. HMSY: Which Stock Is the Better Value Option?

    Sreyoshi Mukherjee headshot

    Bright Near-Term Outlook for Medical Info Systems Industry

    by Sreyoshi Mukherjee

    As the healthcare industry experiences rapid and unprecedented technological changes, let's take a look at a few promising medical info systems stocks.

    Here's Why You Should Hold on to Allscripts Stock for Now

    by Zacks Equity Research

    Allscripts (MDRX) is gaining steadily from strategic acquisitions and solid prospects in Sunrise EHR platform. However, integration risks remain a woe.

    MDRX or CERN: Which Is the Better Value Stock Right Now?

    by Zacks Equity Research

    MDRX vs. CERN: Which Stock Is the Better Value Option?

    Why Is AllScripts (MDRX) Down 7% Since Last Earnings Report?

    by Zacks Equity Research

    AllScripts (MDRX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

    MDRX or CERN: Which Is the Better Value Stock Right Now?

    by Zacks Equity Research

    MDRX vs. CERN: Which Stock Is the Better Value Option?

    San Gorgonio Hospital Picks Allscripts Sunrise Community Care

    by Zacks Equity Research

    Allscripts' (MDRX) Sunrise Community Care is an Azure-hosted platform offering clinical, financial and ambulatory content.

    Is AllScripts Healthcare (MDRX) Stock Undervalued Right Now?

    by Zacks Equity Research

    Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

    MDRX or TRHC: Which Is the Better Value Stock Right Now?

    by Zacks Equity Research

    MDRX vs. TRHC: Which Stock Is the Better Value Option?

    Allscripts (MDRX) Q3 Earnings Beat Estimates, Improve Y/Y

    by Zacks Equity Research

    Allscripts (MDRX) third-quarter results gain from growth in bookings and solid segmental performance. Contraction in both gross and operating margins remains a woe.

    AllScripts Healthcare (MDRX) Beats Q3 Earnings Estimates

    by Zacks Equity Research

    AllScripts (MDRX) delivered earnings and revenue surprises of 6.25% and -1.20%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

    AllScripts Healthcare (MDRX) Expected to Beat Earnings Estimates: Should You Buy?

    by Zacks Equity Research

    AllScripts (MDRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

    Why AllScripts (MDRX) Could Beat Earnings Estimates Again

    by Zacks Equity Research

    AllScripts (MDRX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

    Here's Why You Should Add Allscripts to Your Portfolio Now

    by Zacks Equity Research

    Allscripts' (MDRX) focus on innovation makes it a worthy investment pick.